KINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Equity Movements for November 2025

Bulletin Express12-01

KINTOR PHARMACEUTICAL LIMITED (09939) released its monthly return for November 2025, disclosing no changes to its authorized share capital of 700,000,000 ordinary shares at a par value of USD 0.0001, amounting to USD 70,000 in total.

According to the filing, the total issued shares (excluding treasury shares) increased by 30,487,500, rising from 468,172,600 to 498,660,100. This was attributed to a placement/subscription of new ordinary shares at HKD 1.64, approved at a general meeting on 10 June 2025 and taking effect on 21 November 2025. No changes related to treasury shares, share options, warrants, or convertible securities were reported. The submission also confirmed compliance with relevant listing and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127151107?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127151107","market":"us","top_or_hot":-1,"title":"KINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Equity Movements for November 2025","media":"Bulletin Express","content":"<p>KINTOR PHARMACEUTICAL LIMITED (09939) released its monthly return for November 2025, disclosing no changes to its authorized share capital of 700,000,000 ordinary shares at a par value of USD 0.0001, amounting to USD 70,000 in total.</p>\n<p>According to the filing, the total issued shares (excluding treasury shares) increased by 30,487,500, rising from 468,172,600 to 498,660,100. This was attributed to a placement/subscription of new ordinary shares at HKD 1.64, approved at a general meeting on 10 June 2025 and taking effect on 21 November 2025. No changes related to treasury shares, share options, warrants, or convertible securities were reported. The submission also confirmed compliance with relevant listing and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Equity Movements for November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Equity Movements for November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-01 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>KINTOR PHARMACEUTICAL LIMITED (09939) released its monthly return for November 2025, disclosing no changes to its authorized share capital of 700,000,000 ordinary shares at a par value of USD 0.0001, amounting to USD 70,000 in total.</p>\n<p>According to the filing, the total issued shares (excluding treasury shares) increased by 30,487,500, rising from 468,172,600 to 498,660,100. This was attributed to a placement/subscription of new ordinary shares at HKD 1.64, approved at a general meeting on 10 June 2025 and taking effect on 21 November 2025. No changes related to treasury shares, share options, warrants, or convertible securities were reported. The submission also confirmed compliance with relevant listing and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"","article_id":"1127151107","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127151107","pubTimestamp":1764579925,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"KINTOR PHARMACEUTICAL LIMITED (09939) released its monthly return for November 2025, disclosing no changes to its authorized share capital of 700,000,000 ordinary shares at a par value of USD 0.0001,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09939":"开拓药业-B"},"translate_title":"开拓药业有限公司(09939)公布2025年11月权益变动月","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09939":1},"content_text":"KINTOR PHARMACEUTICAL LIMITED (09939) released its monthly return for November 2025, disclosing no changes to its authorized share capital of 700,000,000 ordinary shares at a par value of USD 0.0001, amounting to USD 70,000 in total.\nAccording to the filing, the total issued shares (excluding treasury shares) increased by 30,487,500, rising from 468,172,600 to 498,660,100. This was attributed to a placement/subscription of new ordinary shares at HKD 1.64, approved at a general meeting on 10 June 2025 and taking effect on 21 November 2025. No changes related to treasury shares, share options, warrants, or convertible securities were reported. The submission also confirmed compliance with relevant listing and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127151107","isCrawlerRequest":true}